blog
I worked with Dr. Blackburn this summer through the Markey STRONG program. My project’s scope focused primarily on the radioresistance associated with missense mutations in TP53, and how those mutations (uniquely) collaborate with the H3K27M mutation found in 80% of…
This summer, I had the opportunity to work in the Blackburn Lab through the Kentucky INBRE Summer Research Program. I investigated Deferoxamine as a drug therapy to prevent relapse in patients with T-cell Acute Lymphoblastic Leukemia. It was an invaluable…
In October 2023 me and Jessi had the chance to go to Durham-North Carolina to attend the 16th Zebrafish Disease Models Society annual meeting. This meeting brings together researchers using zebrafish to model different human diseases. Research findings from the…
During 2023 I worked in Blackburn Lab as visiting scholar and I had an amazing experience. I am professor in Brazil and during this year, I made a training to work with oncology research using zebrafish as animal model. I…
-Trace Jolly, University of Kentucky, Blackburn Lab The Blackburn lab uses zebrafish to study a variety of pediatric cancers. Our lab does this through two main techniques: 1-Transplants and 2- Transgenic Models. Zebrafish transplants/engraftments are a valuable model for examining…
I had the opportunity to attend the 2024 annual meeting of the American Association for Cancer Research (AACR) in San Diego, California. This meeting is one of the largest gatherings in the field of cancer research globally. The AACR annual…
LEXINGTON, Ky. (Aug. 10, 2023) – Using antibodies derived from alpacas, a University of Kentucky research team has developed a tool that could lead to new therapies to stop the growth of several types of cancer. While cancer researchers have known…
This summer I worked under Evelyn as a research assistant where we investigated different, non-traditional drugs as radiosensitizers for DIPG tumors. I did this through culturing SCC127 cells and injecting them into zebrafish embryos and testing these drugs both…
This week I just wrapped up presenting my summer project with Majd on the potential mechanism involving mitochondrial alterations in Amiloride’s targeting of leukemia-initiating cells (LICs) of T-cell lymphoblastic leukemia (T-ALL) through NHE1 inhibition. I was able to look…
This summer marked an important moment in my academic journey as I successfully passed my PhD qualifying exam and I am now a Pharmacology PhD candidate! It has been an incredible experience filled with growth, learning and support from…